News

This potential new Federal Reserve Chair is scheduled to begin the hearing with senators at 10:00 a.m. ET. The market is closely watching this in order to gauge their willingness to cut rates. Tehran has released ambiguous signals regarding a new round of negotiations. Crude oil futures edged down slightly, and the US dollar strengthened. US retail sales in March increased by 1.7%, exceeding expectations. The 10-year Treasury yield stands at 4.268%, higher than yesterday's 4.249%. The 2-year Treasury yield rose from 3.716% to 3.753%.

The current progress of this project is in line with the expected timeline, and all construction phases are proceeding steadily as planned.

The partner led a financing round totaling $5.5 million, aimed at completing the acquisition of Celularity Inc.'s degenerative disease treatment business unit. This strategic financing will significantly accelerate Nexgel's business expansion in the field of cell therapy by integrating Celularity's patented technology platform and clinical assets in degenerative diseases, strengthening its competitiveness in the regenerative medicine market. Sequence Lifescience™, as an innovative platform focused on life sciences investment, spearheaded this financing, demonstrating market recognition of Nexgel's technological approach and commercial prospects. Upon completion of the transaction, Nexgel will gain access to Celularity's R&D pipeline and related intellectual property rights in fields such as neurodegenerative and osteoarticular diseases, further enriching its product portfolio. This acquisition aligns with the company's long-term plans for strategic transformation into high-growth therapeutic areas and is expected to generate significant synergies.